drugset / Trial / NCT07065331
A Study of Inhaled AZD8630 in Adolescents With Asthma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) profile, safety, tolerability, and immunogenicity of single inhaled dose of AZD8630 administered in adolescent participants with asthma as well as the safety and performance of the dry powder inhaler.
Timeline
- Start
- 2025-06-11
- Primary completion
- 2025-09-19
- Completion
- 2025-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8630 | Unknown | — | Inhaled |